Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women

No abstract is available for this paper.

• Publication year

  2011

• Venue

  AIDS (London)

• Publication date

  2011-04-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/QAD.0b013e32834541d9PMID 21330907PMCID PMC3083640
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

  2010cited by this paper
• Results of effectiveness trials of PRO 2000 gel: lessons for future microbicide trials.

  2010cited by this paper
• PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial

  2010cited by this paper
• Limitations of the Dye-Based Method for Determining Vaginal Applicator Use in Microbicide Trials

  2009cited by this paper
• PRO 2000: next steps for microbicide development

  2009cited by this paper
• SAVVY Vaginal Gel (C31G) for Prevention of HIV Infection: A Randomized Controlled Trial in Nigeria

  2008cited by this paper
• Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission.

  2008cited by this paper
• Methodological challenges in biomedical HIV prevention trials.

  2008cited by this paper
• Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.

  2008cited by this paper
• Sensitivity of non-clade B primary HIV-1 isolates to mildly acidic pH.

  2006cited by this paper
• Phase I safety study of 0.5% PRO 2000 vaginal Gel among HIV un-infected women in Pune, India

  2006cited by this paper
• Low pH immobilizes and kills human leukocytes and prevents transmission of cell-associated HIV in a mouse model

  2005cited by this paper
• In Vitro and in Vivo Characterization of a Potential Universal Placebo Designed for Use in Vaginal Microbicide Clinical Trials

  2005cited by this paper
• Some design issues in trials of microbicides for the prevention of HIV infection.

  2004cited by this paper
• EFFECTIVENESS OF COL-1492, A NONOXYNOL-9 VAGINAL GEL, ON HIV-1 TRANSMISSION IN FEMALE SEX WORKERS: A RANDOMISED, CONTROLLED TRIAL

  2003cited by this paper
• Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women

  2003influential reference
• Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial.

  2002cited by this paper
• Effect of nonoxynol-9 gel on urogenital gonorrhea and chlamydial infection: a randomized controlled trial.

  2002cited by this paper
• Tests of BufferGel for Contraception and Prevention of Sexually Transmitted Diseases in Animal Models

  2001cited by this paper
• Phase 1 Trial of the Topical Microbicide BufferGel: Safety Results From Four International Sites

  2001cited by this paper
• Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States.

  2001influential reference
• Evaluation of a Low-Dose Nonoxynol-9 Gel for the Prevention of Sexually Transmitted Diseases: A Randomized Clinical Trial

  2001cited by this paper
• `Chemical condoms’ for the prevention of HIV infection: evaluation of novel agents against SHIV89.6PDin vitro and in vivo

  2001cited by this paper
• Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites.

  2001cited by this paper
• A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women.

  2000cited by this paper
• The rate at which human sperm are immobilized and killed by mild acidity.

  2000cited by this paper
• Acceptability of a novel vaginal microbicide during a safety trial among low-risk women.

  2000influential reference
• The effectiveness of condoms in reducing heterosexual transmission of HIV.

  1999cited by this paper
• A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.

  1998cited by this paper
• HIV/AIDS in Latin America and the Caribbean: an update

  1996cited by this paper
• Female-controlled methods to prevent sexual transmission of HIV.

  1996cited by this paper
• Challenges for the development of female-controlled vaginal microbicides.

  1994cited by this paper
• Development of malabsorption and nutritional complications in simian immunodeficiency virus-infected rhesus macaques

  1994cited by this paper
• Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes.

  1992cited by this paper
• © Joint United Nations Programme on HIV/AIDS

  year unknowncited by this paper

• Review of Impact of Risk Reduction Sessions on Sexual Behaviors in HIV Prevention Trials: Insights from Africa

  2025cites this paper
• Advancing women, maternal, newborn, and child health equity.

  2025cites this paper
• AIDS in Africa-Impact of Research: The 2024 Lasker-Bloomberg Public Service Award.

  2024cites this paper
• Broadly neutralizing antibodies consistently trap HIV-1 in fresh cervicovaginal mucus from select individuals.

  2023cites this paper
• Spatial variations in STIs among women enrolled in HIV prevention clinical trials in Durban, KwaZulu-Natal, South Africa

  2023cites this paper
• Clinical trial simulation to evaluate tenofovir disoproxil fumarate/emtricitabine HIV pre-exposure prophylaxis dosing during pregnancy

  2023cites this paper
• Lactic acid, citric acid, and potassium bitartrate non-hormonal prescription vaginal pH modulator (VPM) gel for the prevention of pregnancy

  2022cites this paper
• Results of a phase 1, randomized, placebo-controlled first-in-human trial of griffithsin formulated in a carrageenan vaginal gel

  2022cites this paper
• Safety of G2-S16 Polyanionic Carbosilane Dendrimer as Possible HIV-1 Vaginal Microbicide

  2022cites this paper
• Hidden heterogeneity: Uncovering patterns of adherence in microbicide trials for HIV prevention

  2022cites this paper
• Special Collection: A pioneer in antiviral drug discovery and development: Commemorating John Martin-Review

  2022cites this paper
• Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled Analysis

  2022cites this paper
• Vaginal epithelial drug delivery.

  2022cites this paper
• Design and methods for the Carrageenan-gel Against Transmission of Cervical Human papillomavirus (CATCH) study: A randomized controlled trial.

  2021cites this paper
• Nanomedicines for the topical treatment of vulvovaginal infections: addressing the challenges of antimicrobial resistance.

  2021cites this paper
• Systematic review on effectiveness of prevention programs for sexually transmitted diseases (STD)

  2021cites this paper
• Temporal and spatial monitoring of HIV prevalence and incidence rates using geospatial models: Results from South African women.

  2021cites this paper
• Topical microbicides for preventing sexually transmitted infections.

  2021cites this paper
• The E cacy and Safety of Topical Microbicide Gels to Prevent Sexual Transmission of Human Immunode ciency Virus (HIV) Infection: a Systematic Review and Meta-analysis

  2021cites this paper
• Lobostemon trigonus (Thunb.) H. Buek, a medicinal plant from South Africa as a potential natural microbicide against HIV-1.

  2021cites this paper
• Evaluation of the novel vaginal contraceptive agent PPCM in preclinical studies using sperm hyaluronan binding and acrosome status assays

  2021cites this paper
• Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa.

  2020cites this paper
• Model-based predictions of HIV incidence among African women using HIV risk behaviors and community-level data on male HIV prevalence and viral suppression.

  2020cites this paper
• Effectiveness of vaginal microbicides in preventing HIV transmission

  2020influential citation
• Temporal trends in sexual behaviours and their impacts on HIV incidence among South African women: 2002–2016

  2020cites this paper
• Model-Based Predictions of HIV Incidence Among African Women Using HIV Risk Behaviors and Community-Level Data on Male HIV Prevalence and Viral Suppression.

  2020cites this paper
• Prevention, Partners, and Power Imbalances: Women's views on how male partners affected their adherence to vaginal microbicide gels during HIV prevention trials in Africa.

  2020cites this paper
• THE IMPACT OF HIV INFECTION ON SURGERY IN SUB-SAHARAN AFRICA: A CLINICAL REVIEW

  2020cites this paper
• Pharmaceutical Vehicles for Vaginal and Rectal Administration of Anti-HIV Microbicide Nanosystems

  2019cites this paper
• A decade of sustained geographic spread of HIV infections among women in Durban, South Africa

  2019cites this paper
• Investigating spatial disparities in high-risk women and HIV infections using generalized additive models: Results from a cohort of South African women.

  2019cites this paper
• Control of HIV/AIDS can be achieved with multi-strategies

  2019cites this paper
• Ecological dynamics of the vaginal microbiome in relation to health and disease

  2019cites this paper
• Correlates of Sexually Transmitted Infections among South African Women Using Individual and Community Level Factors: Results from Generalized Additive Mixed Models

  2019cites this paper
• Combating HIV/AIDS: Biomedical Approaches Towards Prevention

  2019cites this paper
• A novel nested polymerase chain reaction targeting the testis-specific protein Y-encoded family of genes for high sensitivity of recent semen exposure detection: Comparison with four other assays of semen detection

  2019cites this paper
• A phase I randomized safety study of a single-size silicone rubber diaphragm used with or without a lactic-acid-containing diaphragm gel.

  2019cites this paper
• Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study.

  2019cites this paper
• Targeted pregnancy and HIV prevention risk-reduction counselling for young women: lessons learned from biomedical prevention trials Running Title HIV and pregnancy risk-counselling in prevention trials Authors

  2019cites this paper
• Perspectives from Young South African and Zimbabwean Women on Attributes of Four (Placebo) Vaginal Microbicide Delivery Forms

  2019cites this paper
• Clinical testing of antiretroviral drugs as future prevention against vaginal and rectal transmission of HIV infection – a review of currently available results

  2019cites this paper
• Assessing risk for HIV infection among adolescent girls in South Africa: an evaluation of the VOICE risk score (HPTN 068)

  2019cites this paper
• African Women and HIV and AIDS

  2019cites this paper
• Soybean-derived Bowman-Birk inhibitor (BBI) blocks HIV entry into macrophages.

  2018cites this paper
• New prevention and treatment strategies for HIV infection

  2018influential citation
• Evaluation of the reproductive toxicity of antiretroviral drug loaded lactoferrin nanoparticles

  2018cites this paper
• An overview of properties of Amphora (Acidform) contraceptive vaginal gel

  2018cites this paper
• Geographical-level contributions of risk factors for HIV infections using generalized additive models: results from a cohort of South African women

  2018cites this paper
• HIV Antiretroviral Pre‐Exposure Prophylaxis: Development Challenges and Pipeline Promise

  2018cites this paper
• Polymeric gels for intravaginal drug delivery

  2018cites this paper
• Targeted Pregnancy and Human Immunodeficiency Virus Prevention Risk-Reduction Counseling for Young Women: Lessons Learned from Biomedical Prevention Trials

  2018cites this paper
• Computational study of HIV gp120 as a target for polyanionic entry inhibitors: Exploiting the V3 loop region

  2018cites this paper
• User input in iterative design for prevention product development: leveraging interdisciplinary methods to optimize effectiveness

  2017cites this paper
• Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes

  2017influential citation
• Identifying Factors Associated with Low-Adherence and Subsequent HIV Seroconversions Among South African Women Enrolled in a Biomedical Intervention Trial

  2017cites this paper
• A Simple Risk Prediction Algorithm for HIV Transmission: Results from HIV Prevention Trials in KwaZulu Natal, South Africa (2002–2012)

  2017cites this paper
• Uptake of hormonal contraceptives and correlates of uptake in a phase III clinical trial in rural South Western Uganda

  2017influential citation
• Impact of targeted counseling on reported vaginal hygiene practices and bacterial vaginosis: the HIV Prevention Trials Network 035 study

  2017cites this paper
• Without directly observed sex, what's a microbicide trialist to do? : adherence and adherence measurement as a clinical trial design issue in vaginal microbicide trials for HIV prevention

  2017influential citation
• Hydrogels for Vaginal Drug Delivery

  2017cites this paper
• Puerto Rican Women Living with HIV and Experiencing Intimate Partner Violence

  2017cites this paper
• An update of the recombinant protein expression systems of Cyanovirin-N and challenges of preclinical development

  2017cites this paper
• Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial

  2017cites this paper
• Estimating effectiveness in HIV prevention trials with a Bayesian hierarchical compound Poisson frailty model

  2016cites this paper
• Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial.

  2016cites this paper
• Progress and Perspectives on HIV-1 microbicide development.

  2016cites this paper
• Long-term follow-up of HIV seroconverters in microbicide trials – rationale, study design, and challenges in MTN-015

  2016cites this paper
• Triple combination MPT vaginal microbicide using curcumin and efavirenz loaded lactoferrin nanoparticles

  2016cites this paper
• Computational Molecular Design of Cellulose-based Delivery Vehicles for Vaginal Microbicide Gels

  2016cites this paper
• A Phase 1 Trial to Assess the Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics of a Novel Dapivirine Vaginal Film

  2016cites this paper
• Pharmacodynamic correlations using fresh and cryopreserved tissue following use of vaginal rings containing dapivirine and/or maraviroc in a randomized, placebo controlled trial

  2016cites this paper
• Protein/peptide‐based entry/fusion inhibitors as anti‐HIV therapies: challenges and future direction

  2016cites this paper
• The potential of broadly neutralizing HIV antibodies to function as microbicides

  2016influential citation
• An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women

  2016cites this paper
• The effect of HIV counselling and testing on HIV acquisition in sub-Saharan Africa: a systematic review

  2016cites this paper
• Formulaciones vaginales para la prevención del sida I

  2016cites this paper
• Non-Antiretroviral Microbicides for HIV Prevention.

  2016cites this paper
• Efficacy of HIV antiviral polyanionic carbosilane dendrimer G2-S16 in the presence of semen

  2016cites this paper
• Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa

  2016cites this paper
• An update on multipurpose prevention technologies for the prevention of HIV transmission and pregnancy

  2016influential citation
• Barriers to condom use in serodiscordant couples where one partner was on ART at the UZ Clinical Research Centre, Harare, Zimbabwe

  2016cites this paper
• HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities

  2016cites this paper
• Formulaciones vaginales para la prevención del SIDA III

  2016cites this paper
• Acceptability and preferences for vaginal dosage forms intended for prevention of HIV or HIV and pregnancy.

  2015cites this paper
• VAGINAL DELIVERY OF A HYDROPHOBIC ANTIRETROVIRAL DRUG CSIC FOR HIV PREVENTION: NOVEL FORMULATION STRATEGIES FOR IMPROVED DRUG SOLUBILIZATION AND LYMPHATIC TARGETING

  2015cites this paper
• Polymeric anti-HIV therapeutics.

  2015cites this paper
• Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention

  2015cites this paper
• Spatiotemporal Dynamics of HIV Distribution Pattern and Application of Indigenous Bioresources and Microbicides in Expanding Preventive Options

  2015cites this paper
• Measuring Self-Efficacy to Use Vaginal Microbicides: The Microbicide Use Self-Efficacy (MUSE) Instrument

  2015cites this paper
• Blocking HIV-1 transmission in the female reproductive tract: from microbicide development to exploring local antiviral responses

  2015cites this paper
• ‘HIV has a woman's face’: vaginal microbicides and a case of ambiguous failure

  2015cites this paper
• Hormonal Contraception and the Risk of HIV Acquisition: An Individual Participant Data Meta-analysis

  2015cites this paper
• Pharmacodynamic Activity of Dapivirine and Maraviroc Single Entity and Combination Topical Gels for HIV-1 Prevention

  2015cites this paper
• Women and Sexually Transmitted Infections in Africa

  2015cites this paper
• PREFORMULATION AND BIOLOGICAL EVALUATIONS FOR THE INTRAVAGINAL DELIVERY OF GRIFFITHSIN FOR HIV PREVENTION

  2015influential citation
• Antibodies for HIV prevention in young women

  2015cites this paper
• The Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product Development

  2015cites this paper
• PROFILAXIA DE PRÉ-EXPOSIÇÃO DA INFEÇÃO POR VIH

  2015cites this paper
• The Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal Applications

  2015cites this paper
• Broadly Neutralizing Anti-HIV Antibodies Prevent HIV Infection of Mucosal Tissue Ex Vivo

  2015cites this paper